🔴 Biovie is trading 5% down today — no clear company-specific announcement identified

Biovie is trading 5.07% down at $1.97, with no clear company-specific announcement identified for September 9, 2026.

• Recent catalyst remains anticipation of ADDRESS-LC topline results expected before September 30, 2026.
• September 8 coverage concerned FDA engagement for a Parkinson’s Phase 3 program rather than today’s decline.
• Broader markets are modestly lower, but available index moves do not clearly explain this specific move.